Endpoints News 生物医药· Elizabeth Cairns·· 2026-10-02AI 评分13
#EASD26:Regeneron 展望其减肥药物与降脂疗法的结合应用
#EASD26: Regeneron sees a future combining its obesity drug with lipid-lowering therapy
AI 导读
Regeneron 在 EASD26 上展望其肥胖药物与降脂疗法结合的未来。随着更多 GLP-1 类药物进入后期试验并显示更强的减重效果,希望进入市场的公司正探索相关路径。
正文
MILAN — As more GLP-1-based drugs reach late-stage trials and post stronger and stronger weight loss effects, companies that want to enter the market are looking …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news